Orléans, France-based Overseed Biotech, which focuses on agronomic research and development of cannabis-derived medicines, raised 6.7 million euros ($7.25 million) in Series A fundraising round with the goal of becoming the first French manufacturer of 100% medical cannabis medicines,writes EU-Startups. “On the French market, we are 2 to 3 years ahead in terms of manufacturing expertise, and will be ready to offer high-quality, high-volume production from day 1,” stated Hugues Péribère, CEO and founder of Overseed. “This financing is the final sprint to market access. We are counting on the in…